Team Consulting role in $295m diagnostics platform sale to Roche

Cambridge Cluster medical device and development consultancy, Team Consulting, has helped a globally successful client clinch $295 million in a significant healthcare sector deal.

Nasdaq-quoted LumiraDx secured the haul from the sale of its point of care diagnostics platform to Roche – a Swiss multinational healthcare company that operates worldwide under two divisions, Pharmaceuticals and Diagnostics.

Lumira worked closely with Team Consulting to develop the platform which the Cambridge business says offers “a remarkable advancement in enhancing patient access to diagnostic testing.”

Over the full development project Team Consulting helped LumiraDx create a diagnostic platform that “transformed point of care testing, providing lab comparable results in minutes.”

The platform enables testing to be performed at or near the patients’ location, eliminating the need to send samples to a central laboratory. 

Liz Thorn, Head of Diagnostics at Team Consulting, was delighted by the outcome for the client. She said: “This technology has now become more widely available thanks to this deal with Roche Diagnostics. What a fantastic start to 2024!” 

For the past 37 years, Team Consulting, based in Ickleton, is known for having consistently crafted cutting-edge medical devices – collaborating with a diverse range of clients from prominent pharmaceutical giants to innovative startups. 

Team clients are active across all phases of healthcare technology development – ranging from large pharmaceutical companies to startups. 

LumiraDx, which locally has operations in Bedford, has its global headquarters in the Cayman Islands and US facilities in San Diego, California and Waltham, Massachusetts.